Oncternal Therapeutics Inc (ONCT)
Cours de l'action
Résultats financiers
Value bought
90 derniers jours
Value sold
90 derniers jours
Net insiders buying
90 derniers jours
Trades (buy and sell)
90 derniers jours
Rechercher
| Date de notification | Date de transaction | A/V Type de transaction | Initié et/ou titre |
Nb. d'actions Prix Valeur |
Nombre d'actions | Prix | Valeur | Détails |
|---|---|---|---|---|---|---|---|---|
| 2024-04-10 | 2024-04-08 | A Achat | Administrateur non-exécutif |
3 086
+44.6%
8,9627 655 USD |
3 086 +44.6% | 8,96 | 27 655 USD | |
| 2024-04-01 | 2024-03-28 | A Achat | Administrateur non-exécutif |
6 914
+inf%
8,4858 602 USD |
6 914 +inf% | 8,48 | 58 602 USD | |
| 2024-02-27 | 2024-02-23 | V Vente | Administrateur non-exécutif |
980
-100.0%
9,048 859 USD |
980 -100.0% | 9,04 | 8 859 USD | |
| 2024-02-27 | 2024-02-23 | A Achat | Administrateur non-exécutif |
266
+0.9%
9,042 405 USD |
266 +0.9% | 9,04 | 2 405 USD | |
| 2024-02-27 | 2024-02-23 | A Achat | Administrateur non-exécutif |
714
+inf%
9,046 455 USD |
714 +inf% | 9,04 | 6 455 USD | |
| 2023-06-14 | 2023-06-14 | A Achat |
Chief Scientific Officer Dirigeant |
3 000
+3.3%
0,361 079 USD |
3 000 +3.3% | 0,36 | 1 079 USD | |
| 2023-06-14 | 2023-06-12 | A Achat |
Chief Scientific Officer Dirigeant |
25 000
+37.5%
0,358 745 USD |
25 000 +37.5% | 0,35 | 8 745 USD | |
| 2023-04-17 | 2023-04-14 | A Achat |
Chief Executive Officer Administrateur exécutif |
2 250
+1.2%
0,29653 USD |
2 250 +1.2% | 0,29 | 653 USD | |
| 2023-04-17 | 2023-04-14 | A Achat |
Chief Executive Officer Administrateur exécutif |
47 750
+32.6%
0,3014 277 USD |
47 750 +32.6% | 0,30 | 14 277 USD | |
| 2023-04-14 | 2023-04-14 | A Achat |
Chief Medical Officer Dirigeant |
5 000
+3.1%
0,301 500 USD |
5 000 +3.1% | 0,30 | 1 500 USD | |
| 2023-04-17 | 2023-04-13 | A Achat |
Chief Executive Officer Administrateur exécutif |
100 000
+214.9%
0,2929 000 USD |
100 000 +214.9% | 0,29 | 29 000 USD | |
| 2023-04-14 | 2023-04-13 | A Achat |
Chief Financial Officer Dirigeant |
30 000
+23.6%
0,308 961 USD |
30 000 +23.6% | 0,30 | 8 961 USD | |
| 2023-04-14 | 2023-04-13 | A Achat |
Chief Medical Officer Dirigeant |
10 000
+6.7%
0,292 850 USD |
10 000 +6.7% | 0,29 | 2 850 USD | |
| 2023-04-14 | 2023-04-13 | A Achat |
General Counsel/Secretary Dirigeant |
10 000
+10.3%
0,292 900 USD |
10 000 +10.3% | 0,29 | 2 900 USD | |
| 2023-04-14 | 2023-04-12 | A Achat |
Chief Medical Officer Dirigeant |
10 000
+7.2%
0,292 850 USD |
10 000 +7.2% | 0,29 | 2 850 USD | |
| 2023-04-14 | 2023-04-12 | A Achat |
General Counsel/Secretary Dirigeant |
15 000
+18.3%
0,294 350 USD |
15 000 +18.3% | 0,29 | 4 350 USD | |
| 2022-03-28 | 2022-03-28 | A Achat |
Chief Financial Officer Dirigeant |
2 500
+2.9%
1,403 500 USD |
2 500 +2.9% | 1,40 | 3 500 USD | |
| 2022-03-28 | 2022-03-25 | A Achat |
Chief Financial Officer Dirigeant |
2 136
+2.6%
1,493 182 USD |
2 136 +2.6% | 1,49 | 3 182 USD | |
| 2022-03-28 | 2022-03-25 | A Achat |
Chief Financial Officer Dirigeant |
5
+0.0%
1,487 USD |
5 +0.0% | 1,48 | 7 USD | |
| 2022-03-28 | 2022-03-25 | A Achat |
Chief Financial Officer Dirigeant |
356
+0.4%
1,45516 USD |
356 +0.4% | 1,45 | 516 USD | |
| 2022-03-28 | 2022-03-24 | A Achat |
Chief Financial Officer Dirigeant |
3
+0.0%
1,454 USD |
3 +0.0% | 1,45 | 4 USD | |
| 2022-01-31 | 2022-01-28 | A Achat |
Chief Financial Officer Dirigeant |
2 500
+3.1%
1,654 125 USD |
2 500 +3.1% | 1,65 | 4 125 USD | |
| 2022-01-31 | 2022-01-28 | A Achat |
General Counsel/Secretary Dirigeant |
5 000
+12.5%
1,638 150 USD |
5 000 +12.5% | 1,63 | 8 150 USD | |
| 2022-01-31 | 2022-01-27 | A Achat |
Chief Financial Officer Dirigeant |
5 000
+6.6%
1,708 500 USD |
5 000 +6.6% | 1,70 | 8 500 USD | |
| 2022-01-31 | 2022-01-27 | A Achat |
Chief Financial Officer Dirigeant |
5 000
+7.1%
1,809 000 USD |
5 000 +7.1% | 1,80 | 9 000 USD | |
| 2022-01-31 | 2022-01-27 | A Achat |
Chief Executive Officer Administrateur exécutif |
25 000
+116.0%
1,6842 080 USD |
25 000 +116.0% | 1,68 | 42 080 USD | |
| 2022-01-31 | 2022-01-27 | A Achat |
General Counsel/Secretary Dirigeant |
8 500
+27.1%
1,7815 130 USD |
8 500 +27.1% | 1,78 | 15 130 USD | |
| 2022-01-31 | 2022-01-27 | A Achat |
Chief Medical Officer Dirigeant |
10 000
+17.5%
1,6916 900 USD |
10 000 +17.5% | 1,69 | 16 900 USD | |
| 2021-06-15 | 2021-06-11 | A Achat |
General Counsel/Secretary Dirigeant |
1 500
+inf%
5,458 175 USD |
1 500 +inf% | 5,45 | 8 175 USD | |
| 2020-09-02 | 2020-09-01 | A Achat | Administrateur non-exécutif |
71 429
+13789.4%
2,10150 001 USD |
71 429 +13789.4% | 2,10 | 150 001 USD | |
| 2020-07-23 | 2020-07-21 | A Achat |
Shanghai Pharmaceutical (USA) Inc. Actionnaire important |
1 049 317
+42.1%
2,382 499 998 USD |
1 049 317 +42.1% | 2,38 | 2 499 998 USD | |
| 2020-07-23 | 2020-07-21 | A Achat | Administrateur non-exécutif |
10 000
+inf%
2,3823 825 USD |
10 000 +inf% | 2,38 | 23 825 USD | |
| 2020-07-23 | 2020-07-21 | A Achat |
Legal Counsel Dirigeant |
41 972
+836.9%
2,3899 998 USD |
41 972 +836.9% | 2,38 | 99 998 USD | |
| 2020-05-22 | 2020-05-21 | A Achat | Administrateur non-exécutif |
17 412
0,000 USD |
17 412 | 0,00 | 0 USD | |
| 2018-06-26 | 2018-06-26 | A Achat |
Wills Robert James Executive Chairman Administrateur exécutif |
5 000
+3.8%
16,7583 750 USD |
5 000 +3.8% | 16,75 | 83 750 USD | |
| 2018-06-22 | 2018-06-20 | V Vente |
DOGGRELL HENRY PATTON VP, Chief Legal Officer |
7 351
-14.4%
19,01139 708 USD |
7 351 -14.4% | 19,01 | 139 708 USD | |
| 2018-06-22 | 2018-06-20 | V Vente |
Shackelford Jason T Prin Fin. & Acct. Officer |
9 279
-32.3%
19,01176 350 USD |
9 279 -32.3% | 19,01 | 176 350 USD | |
| 2018-01-09 | 2018-01-05 | V Vente |
Shackelford Jason T Prin Fin. & Acct. Officer Dirigeant |
2 379
-7.6%
11,1326 478 USD |
2 379 -7.6% | 11,13 | 26 478 USD | |
| 2018-01-09 | 2018-01-05 | V Vente |
Prin Fin. & Acct. Officer Dirigeant |
711
-2.2%
12,028 546 USD |
711 -2.2% | 12,02 | 8 546 USD | |
| 2018-01-09 | 2018-01-05 | V Vente |
DOGGRELL HENRY PATTON VP, Chief Legal Officer Dirigeant |
3 823
-7.0%
11,1342 550 USD |
3 823 -7.0% | 11,13 | 42 550 USD | |
| 2018-01-09 | 2018-01-05 | V Vente |
DOGGRELL HENRY PATTON VP, Chief Legal Officer Dirigeant |
1 142
-2.0%
12,0213 727 USD |
1 142 -2.0% | 12,02 | 13 727 USD | |
| 2018-01-09 | 2018-01-05 | V Vente |
HANOVER MARC STEVEN Chief Executive Officer Administrateur exécutif |
5 628
-4.3%
11,1362 640 USD |
5 628 -4.3% | 11,13 | 62 640 USD | |
| 2018-01-09 | 2018-01-05 | V Vente |
HANOVER MARC STEVEN Chief Executive Officer Administrateur exécutif |
1 681
-1.3%
12,0220 206 USD |
1 681 -1.3% | 12,02 | 20 206 USD | |
| 2017-10-02 | 2017-09-29 | A Achat |
Pyramid Peak Foundation Actionnaire important |
565 291
0,000 USD |
565 291 | 0,00 | 0 USD | |
| 2017-02-28 | 2016-10-28 | V Vente |
Young Diane C. VP, Chief Medical Officer |
500
-100.0%
7,703 850 USD |
500 -100.0% | 7,70 | 3 850 USD | |
| 2016-10-17 | 2016-10-14 | A Achat |
Pyramid Peak Foundation Actionnaire important |
7 716 049
+25.3%
0,816 250 000 USD |
7 716 049 +25.3% | 0,81 | 6 250 000 USD | |
| 2016-06-20 | 2016-06-16 | A Achat |
Wills Robert James Executive Chairman Administrateur exécutif |
100 000
+9.1%
0,6565 360 USD |
100 000 +9.1% | 0,65 | 65 360 USD | |
| 2016-03-02 | 2016-03-01 | A Achat |
GLASS J KENNETH Administrateur non-exécutif |
44 000
+31.5%
0,6026 400 USD |
44 000 +31.5% | 0,60 | 26 400 USD | |
| 2016-01-26 | 2016-01-26 | A Achat |
HANOVER MARC STEVEN Chief Executive Officer Administrateur exécutif |
4 000
+0.3%
0,652 600 USD |
4 000 +0.3% | 0,65 | 2 600 USD | |
| 2016-01-25 | 2016-01-25 | A Achat |
HANOVER MARC STEVEN Chief Executive Officer Administrateur exécutif |
12 813
+1.0%
0,638 067 USD |
12 813 +1.0% | 0,63 | 8 067 USD | |
| 2016-01-19 | 2016-01-19 | A Achat |
HANOVER MARC STEVEN Chief Executive Officer Administrateur exécutif |
25 000
+2.1%
0,5012 428 USD |
25 000 +2.1% | 0,50 | 12 428 USD | |
| 2016-01-15 | 2016-01-15 | A Achat |
HANOVER MARC STEVEN Chief Executive Officer Administrateur exécutif |
22 100
+1.9%
0,4910 889 USD |
22 100 +1.9% | 0,49 | 10 889 USD | |
| 2016-01-15 | 2016-01-14 | A Achat |
HANOVER MARC STEVEN Chief Executive Officer Administrateur exécutif |
2 900
+0.2%
0,471 377 USD |
2 900 +0.2% | 0,47 | 1 377 USD | |
| 2015-12-28 | 2015-12-24 | A Achat |
GLASS J KENNETH Administrateur non-exécutif |
100
+0.1%
0,7979 USD |
100 +0.1% | 0,79 | 79 USD | |
| 2015-12-23 | 2015-12-23 | A Achat |
GLASS J KENNETH Administrateur non-exécutif |
600
+0.4%
0,79474 USD |
600 +0.4% | 0,79 | 474 USD | |
| 2015-12-23 | 2015-12-22 | A Achat |
GLASS J KENNETH Administrateur non-exécutif |
1 307
+0.9%
0,781 019 USD |
1 307 +0.9% | 0,78 | 1 019 USD | |
| 2015-12-21 | 2015-12-21 | A Achat |
GLASS J KENNETH Administrateur non-exécutif |
39 900
+40.8%
0,7831 122 USD |
39 900 +40.8% | 0,78 | 31 122 USD | |
| 2015-05-20 | 2015-05-19 | A Achat |
GLASS J KENNETH Administrateur non-exécutif |
24 500
+inf%
1,2530 625 USD |
24 500 +inf% | 1,25 | 30 625 USD | |
| 2015-05-14 | 2015-05-14 | A Achat |
Wills Robert James Executive Chairman Administrateur exécutif |
36 440
+57.3%
0,9835 711 USD |
36 440 +57.3% | 0,98 | 35 711 USD | |
| 2015-05-14 | 2015-05-13 | A Achat |
Wills Robert James Executive Chairman Administrateur exécutif |
9 700
+18.0%
0,888 536 USD |
9 700 +18.0% | 0,88 | 8 536 USD | |
| 2015-05-13 | 2015-05-11 | A Achat |
Wills Robert James Executive Chairman Administrateur exécutif |
3 860
+7.7%
0,803 088 USD |
3 860 +7.7% | 0,80 | 3 088 USD | |
| 2015-05-11 | 2015-05-08 | A Achat |
DOGGRELL HENRY PATTON VP, Chief Legal Officer Dirigeant |
25 477
+inf%
0,8020 382 USD |
25 477 +inf% | 0,80 | 20 382 USD | |
| 2015-05-11 | 2015-05-08 | A Achat |
Wills Robert James Executive Chairman Administrateur exécutif |
50 000
+inf%
0,8040 000 USD |
50 000 +inf% | 0,80 | 40 000 USD | |
| 2015-04-23 | 2015-04-22 | A Achat |
GLASS J KENNETH Administrateur non-exécutif |
10 000
+11.4%
0,727 200 USD |
10 000 +11.4% | 0,72 | 7 200 USD | |
| 2015-04-22 | 2015-04-21 | A Achat |
GLASS J KENNETH Administrateur non-exécutif |
7 656
+9.5%
0,715 436 USD |
7 656 +9.5% | 0,71 | 5 436 USD | |
| 2015-04-22 | 2015-04-20 | A Achat |
GLASS J KENNETH Administrateur non-exécutif |
3 952
+5.2%
0,722 845 USD |
3 952 +5.2% | 0,72 | 2 845 USD | |
| 2015-04-15 | 2015-04-15 | A Achat |
GLASS J KENNETH Administrateur non-exécutif |
3 300
+4.5%
0,722 376 USD |
3 300 +4.5% | 0,72 | 2 376 USD | |
| 2015-04-13 | 2015-04-10 | A Achat |
GLASS J KENNETH Administrateur non-exécutif |
16 400
+29.0%
0,6710 988 USD |
16 400 +29.0% | 0,67 | 10 988 USD | |
| 2014-09-23 | 2014-09-23 | A Achat |
HANOVER MARC STEVEN Interim CEO, President and COO Administrateur exécutif |
5 000
+2.4%
0,753 750 USD |
5 000 +2.4% | 0,75 | 3 750 USD | |
| 2014-09-17 | 2014-09-17 | A Achat |
HANOVER MARC STEVEN Interim CEO, President and COO Administrateur exécutif |
10 000
+5.0%
0,747 432 USD |
10 000 +5.0% | 0,74 | 7 432 USD | |
| 2014-08-21 | 2014-08-21 | A Achat |
HANOVER MARC STEVEN Interim CEO, President and COO Administrateur exécutif |
10 000
+5.3%
1,0010 000 USD |
10 000 +5.3% | 1,00 | 10 000 USD | |
| 2014-08-21 | 2014-08-20 | A Achat |
HANOVER MARC STEVEN Interim CEO, President and COO Administrateur exécutif |
10 000
+5.6%
1,0010 000 USD |
10 000 +5.6% | 1,00 | 10 000 USD | |
| 2014-08-19 | 2014-08-19 | A Achat |
HANOVER MARC STEVEN Interim CEO, President and COO Administrateur exécutif |
8 348
+4.9%
1,018 448 USD |
8 348 +4.9% | 1,01 | 8 448 USD | |
| 2014-08-19 | 2014-08-15 | A Achat |
HANOVER MARC STEVEN Interim CEO, President and COO Administrateur exécutif |
1 652
+1.0%
1,001 652 USD |
1 652 +1.0% | 1,00 | 1 652 USD | |
| 2014-08-08 | 2014-08-08 | A Achat |
HANOVER MARC STEVEN Interim CEO, President and COO Administrateur exécutif |
10 000
+6.3%
0,959 532 USD |
10 000 +6.3% | 0,95 | 9 532 USD |